Clinical Trial Update: Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial of oxaliplatin for patients with recurrent or refractory ovarian epithelial cancer or primary peritoneal cancer that did not respond to platinum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED